首页 > 最新文献

Journal of the International Association of Providers of AIDS Care最新文献

英文 中文
Don't Wait Till Tomorrow: How to Support Underrepresented Undergraduate HIV Researchers Today From the Voices of Emerging Leaders. 不要等到明天:如何支持代表性不足的大学生艾滋病研究人员今天从新兴领导人的声音。
IF 2.1 Q3 INFECTIOUS DISEASES Pub Date : 2025-01-01 Epub Date: 2025-11-20 DOI: 10.1177/23259582251395779
Evan Hall, Myla Lyons

Undergraduate, underrepresented minority (URM) scholars must be comprehensively supported by the current HIV workforce to lead the future of HIV research. This commentary elaborates on the lived experience and outcomes of alumni from an undergraduate HIV research program and is written by alumni themselves. Undergraduate research enrichment programs for URM scholars are consistently deprioritized, underfunded, underresourced, and scrutinized. We seek to remind our audience of the outstanding contributions made to HIV and public health by URM scholars from these programs, such as the Student Opportunities for AIDS/HIV Research (SOAR) program. SOAR students and alumni report 95% placement in Masters, Doctoral, and Professional graduate programs, 100 conference presentations, and 34 publications within 3 years of the program's onset. Ultimately, this commentary speaks to the necessity of not only supporting URM researchers but also having a sustainable succession plan for advancing HIV research and programming. We recommend incorporating (a) critical health equity curriculum, (b) multidirectional mentorship, and (c) paid labor, which are crucial to tailor to URM scholars for their success and retention in research. Waiting to support the next generation of HIV researchers denies the urgency to respond to this intersectional public health issue-inaction is not an option.

本科生、未被充分代表的少数族裔(URM)学者必须得到当前艾滋病毒工作人员的全面支持,以领导未来的艾滋病毒研究。这篇评论详细阐述了校友们的生活经历和成果,他们来自一个本科艾滋病研究项目,是校友们自己写的。URM学者的本科研究充实计划一直被剥夺优先权,资金不足,资源不足,并受到严格审查。我们试图提醒我们的听众,来自这些项目的URM学者对艾滋病毒和公共卫生做出了杰出贡献,例如艾滋病/艾滋病毒研究学生机会(SOAR)项目。据报道,在项目启动的三年内,SOAR的学生和校友有95%的人参加了硕士、博士和专业研究生课程,发表了100次会议演讲,发表了34篇论文。最终,这篇评论表明,不仅需要支持URM的研究人员,而且需要有一个可持续的继任计划来推进艾滋病毒的研究和规划。我们建议纳入(a)关键的健康公平课程,(b)多向指导,以及(c)有偿劳动,这对于为URM学者量身定制他们在研究中的成功和保留至关重要。等待支持下一代艾滋病毒研究人员否认了应对这一交叉公共卫生问题的紧迫性——不作为不是一种选择。
{"title":"Don't Wait Till Tomorrow: How to Support Underrepresented Undergraduate HIV Researchers Today From the Voices of Emerging Leaders.","authors":"Evan Hall, Myla Lyons","doi":"10.1177/23259582251395779","DOIUrl":"10.1177/23259582251395779","url":null,"abstract":"<p><p>Undergraduate, underrepresented minority (URM) scholars must be comprehensively supported by the current HIV workforce to lead the future of HIV research. This commentary elaborates on the lived experience and outcomes of alumni from an undergraduate HIV research program and is written by alumni themselves. Undergraduate research enrichment programs for URM scholars are consistently deprioritized, underfunded, underresourced, and scrutinized. We seek to remind our audience of the outstanding contributions made to HIV and public health by URM scholars from these programs, such as the Student Opportunities for AIDS/HIV Research (SOAR) program. SOAR students and alumni report 95% placement in Masters, Doctoral, and Professional graduate programs, 100 conference presentations, and 34 publications within 3 years of the program's onset. Ultimately, this commentary speaks to the necessity of not only supporting URM researchers but also having a sustainable succession plan for advancing HIV research and programming. We recommend incorporating (a) critical health equity curriculum, (b) multidirectional mentorship, and (c) paid labor, which are crucial to tailor to URM scholars for their success and retention in research. Waiting to support the next generation of HIV researchers denies the urgency to respond to this intersectional public health issue-inaction is not an option.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"24 ","pages":"23259582251395779"},"PeriodicalIF":2.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12638703/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145564386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dyslipidemia and Associated Factors Among People Living With HIV on Dolutegravir-Based Antiretroviral Therapy in Central Uganda. 在乌干达中部接受以多路地韦为基础的抗逆转录病毒治疗的艾滋病毒感染者中血脂异常和相关因素
IF 2.1 Q3 INFECTIOUS DISEASES Pub Date : 2025-01-01 Epub Date: 2025-11-12 DOI: 10.1177/23259582251395549
Flavia Timbigamba, Charles Nkubi Bagenda, Hendry Sembogga, Timothy Wasswa, Faizo Bazibu, Joseph Ssali, Elastus Ssemwanga, Michael Junior Mugisa, Edwin Nuwagaba, Samuel Ojuko, Carol Nantongo, Jesca Akoth Wafwoyo, Benson Musinguzi, Winnie Akiteng, Lawrence Obado Osuwat

Introduction: Dolutegravir (DTG)-based antiretroviral therapy (ART) use has been associated with excessive weight gain, increasing the risk of dyslipidemias such as hypercholesterolemia. We assessed the prevalence of, and associated factors with dyslipidemia among adults on DTG-based ART.Materials and methodsWe conducted a cross-sectional study among 281 systematically sampled adults on DTG-based ART for ≥ 6 months at Kira Health Centre IV, Wakiso District, Central Uganda. Data were collected through structured questionnaires, medical record reviews, anthropometric measurements, and laboratory biomarker analysis. Logistic regression was used to determine associated factors, and the predictive performance of obesity indices was evaluated using receiver operating characteristic (ROC) curve analysis.ResultsThe prevalence of dyslipidemia was 44.1% 95% CI: 38.4%-50.0%. Low high-density lipoprotein (HDL) cholesterol was the most common abnormality, affecting 39.9% of participants, followed by elevated total cholesterol at 5.7% [95% CI: 3.51-9.11] and elevated low-density lipoprotein (LDL) cholesterol at 5.0%. High waist circumference (WC) was significantly associated with dyslipidemia; (aPR: 1.93, 95% CI: 1.15-3.24, p = .013), and demonstrated a significant ability to predict dyslipidemia with area under the curve (AUC) of 0.577 [95% CI: 0.511-0.644]. The AUC for WC in predicting hypercholesterolemia, elevated LDL-C, and low HDL-C were 0.702 (95% CI: 0.547-0.857), 0.729(95% CI: 0.590-0.867), and 0.548 (95% CI: 0.481-0.616) respectively.ConclusionDyslipidemia is prevalent among adults on DTG-based ART, and is potentially associated with high WC.

以多替格拉韦(DTG)为基础的抗逆转录病毒治疗(ART)的使用与体重过度增加有关,增加了血脂异常(如高胆固醇血症)的风险。我们评估了接受dtg为基础的ART治疗的成人中血脂异常的患病率和相关因素。材料和方法我们在乌干达中部Wakiso区的基拉第四卫生中心对281名接受dtg为基础的抗逆转录病毒治疗≥6个月的系统抽样成年人进行了横断面研究。通过结构化问卷调查、医疗记录回顾、人体测量和实验室生物标志物分析收集数据。采用Logistic回归确定相关因素,采用受试者工作特征(ROC)曲线分析评价肥胖指标的预测效能。结果血脂异常患病率为44.1%,95% CI: 38.4% ~ 50.0%。低高密度脂蛋白(HDL)胆固醇是最常见的异常,影响了39.9%的参与者,其次是5.7%的总胆固醇升高[95% CI: 3.51-9.11]和5.0%的低密度脂蛋白(LDL)胆固醇升高。高腰围(WC)与血脂异常显著相关;(aPR: 1.93, 95% CI: 1.15 ~ 3.24, p =。013),并且曲线下面积(AUC)为0.577 (95% CI: 0.511-0.644),显示出预测血脂异常的显著能力。WC预测高胆固醇血症、LDL-C升高和HDL-C降低的AUC分别为0.702 (95% CI: 0.547-0.857)、0.729(95% CI: 0.590-0.867)和0.548 (95% CI: 0.481-0.616)。结论在接受dtg为基础的ART治疗的成人中,血脂异常普遍存在,且可能与高WC有关。
{"title":"Dyslipidemia and Associated Factors Among People Living With HIV on Dolutegravir-Based Antiretroviral Therapy in Central Uganda.","authors":"Flavia Timbigamba, Charles Nkubi Bagenda, Hendry Sembogga, Timothy Wasswa, Faizo Bazibu, Joseph Ssali, Elastus Ssemwanga, Michael Junior Mugisa, Edwin Nuwagaba, Samuel Ojuko, Carol Nantongo, Jesca Akoth Wafwoyo, Benson Musinguzi, Winnie Akiteng, Lawrence Obado Osuwat","doi":"10.1177/23259582251395549","DOIUrl":"10.1177/23259582251395549","url":null,"abstract":"<p><strong>Introduction: </strong>Dolutegravir (DTG)-based antiretroviral therapy (ART) use has been associated with excessive weight gain, increasing the risk of dyslipidemias such as hypercholesterolemia. We assessed the prevalence of, and associated factors with dyslipidemia among adults on DTG-based ART.Materials and methodsWe conducted a cross-sectional study among 281 systematically sampled adults on DTG-based ART for ≥ 6 months at Kira Health Centre IV, Wakiso District, Central Uganda. Data were collected through structured questionnaires, medical record reviews, anthropometric measurements, and laboratory biomarker analysis. Logistic regression was used to determine associated factors, and the predictive performance of obesity indices was evaluated using receiver operating characteristic (ROC) curve analysis.ResultsThe prevalence of dyslipidemia was 44.1% 95% CI: 38.4%-50.0%. Low high-density lipoprotein (HDL) cholesterol was the most common abnormality, affecting 39.9% of participants, followed by elevated total cholesterol at 5.7% [95% CI: 3.51-9.11] and elevated low-density lipoprotein (LDL) cholesterol at 5.0%. High waist circumference (WC) was significantly associated with dyslipidemia; (aPR: 1.93, 95% CI: 1.15-3.24, <i>p</i> = .013), and demonstrated a significant ability to predict dyslipidemia with area under the curve (AUC) of 0.577 [95% CI: 0.511-0.644]. The AUC for WC in predicting hypercholesterolemia, elevated LDL-C, and low HDL-C were 0.702 (95% CI: 0.547-0.857), 0.729(95% CI: 0.590-0.867), and 0.548 (95% CI: 0.481-0.616) respectively.ConclusionDyslipidemia is prevalent among adults on DTG-based ART, and is potentially associated with high WC.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"24 ","pages":"23259582251395549"},"PeriodicalIF":2.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12612514/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145505158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of Intrinsic Motivation for HIV Self-Care: Photovoice of Young People Living with Perinatal HIV in Northern Thailand. 艾滋病毒自我护理的内在动机识别:泰国北部围产期艾滋病毒感染者的照片语音。
IF 2.1 Q3 INFECTIOUS DISEASES Pub Date : 2025-01-01 Epub Date: 2025-12-10 DOI: 10.1177/23259582251400817
Linda Aurpibul, Chintana Khamrong, Kalunyu Kotchawat, Rattika Thammalangka, Wanvisa Taweehorm, Supunnee Masurin, Nuttawadee Maneerat

ObjectiveYoung people with perinatally acquired HIV (YPHIV) in Thailand face psychosocial, developmental, and structural challenges. Intrinsic motivation strongly shapes health behaviors, including treatment adherence and Human immunodeficiency virus (HIV) self-care.MethodsA qualitative study was conducted in March 2025 at the Chiang Mai University in Thailand enrolling 32 YPHIV aged 16-30 years (median age 22.9). Using photovoice and focus group discussions, participants shared their experiences and motivations for self-care.ResultsThematic analysis revealed key sources of motivation: supportive family ties, self-value, ambitious life goals, and inspiration from nature. While medication adherence and HIV self-care were seen as manageable, disclosure of HIV status remained highly stressful.ConclusionFindings suggest YPHIV demonstrates resilience and intrinsic motivation despite ongoing challenges. Strengthening intrinsic motivation may enhance adherence, self-care, and long-term health outcomes through timely interventions and social support.

泰国围产期获得性艾滋病毒(YPHIV)的年轻人面临着社会心理、发育和结构方面的挑战。内在动机强烈地塑造健康行为,包括治疗依从性和人类免疫缺陷病毒(HIV)自我保健。方法于2025年3月在泰国清迈大学进行了一项定性研究,招募了32名年龄在16-30岁(中位年龄22.9岁)的YPHIV。参加者透过photovoice和焦点小组讨论,分享自我照顾的经验和动机。结果主题分析揭示了动机的主要来源:支持性的家庭关系、自我价值、远大的人生目标和来自大自然的灵感。虽然药物依从性和艾滋病毒自我护理被认为是可控的,但披露艾滋病毒状况仍然是高度紧张的。结论研究结果表明,尽管面临持续的挑战,YPHIV仍表现出弹性和内在动机。通过及时的干预和社会支持,加强内在动机可以增强依从性、自我保健和长期健康结果。
{"title":"Identification of Intrinsic Motivation for HIV Self-Care: Photovoice of Young People Living with Perinatal HIV in Northern Thailand.","authors":"Linda Aurpibul, Chintana Khamrong, Kalunyu Kotchawat, Rattika Thammalangka, Wanvisa Taweehorm, Supunnee Masurin, Nuttawadee Maneerat","doi":"10.1177/23259582251400817","DOIUrl":"10.1177/23259582251400817","url":null,"abstract":"<p><p>ObjectiveYoung people with perinatally acquired HIV (YPHIV) in Thailand face psychosocial, developmental, and structural challenges. Intrinsic motivation strongly shapes health behaviors, including treatment adherence and Human immunodeficiency virus (HIV) self-care.MethodsA qualitative study was conducted in March 2025 at the Chiang Mai University in Thailand enrolling 32 YPHIV aged 16-30 years (median age 22.9). Using photovoice and focus group discussions, participants shared their experiences and motivations for self-care.ResultsThematic analysis revealed key sources of motivation: supportive family ties, self-value, ambitious life goals, and inspiration from nature. While medication adherence and HIV self-care were seen as manageable, disclosure of HIV status remained highly stressful.ConclusionFindings suggest YPHIV demonstrates resilience and intrinsic motivation despite ongoing challenges. Strengthening intrinsic motivation may enhance adherence, self-care, and long-term health outcomes through timely interventions and social support.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"24 ","pages":"23259582251400817"},"PeriodicalIF":2.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12698992/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145723825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Outcomes of a Nurse-Delivered, Technology-Enabled HIV Outpatient Model. 由护士提供的技术辅助型艾滋病门诊模式的临床效果。
IF 2.2 Q3 INFECTIOUS DISEASES Pub Date : 2024-01-01 DOI: 10.1177/23259582241274304
Sara Day, Rebecca Wilkins, Andrew Murungi, Christina Antoniadi, Yodit Fissahaye-Yimer, Samuel Ohene-Adomako, David Asboe, Caroline Rae

We evaluated Klick, a nurse-led, digitally enabled model of HIV outpatient care, launched in 2020. Klick's smartphone app offers online booking, remote nurse-led consultations, and results. An audit of Klick nurse-led consultations was conducted against BHIVA monitoring guidelines, and nurses were interviewed about their experience. Of 40 Klick patients audited, 4 of 5 BHIVA standards were met: 100% had documented co-medications, smoking history, blood pressure, and viral load data, and 89% received a cardiovascular risk calculation (Targets 97%-90%-90%-90%-90%). Compared to national BHIVA audit findings, Klick performed better across 22 of 24 comparable measures. Nurses safely managed a cohort comprising some complexity (eg, co-morbidities, polypharmacy); no cases were escalated off the pathway, and all were virologically suppressed. Using a digitally supported model, nurses effectively provided safe care to HIV-positive patients with predominantly stable health, enabling consultants to focus on more complex caseloads. Care was comprehensive and person-centered and obtained better outcomes compared to previous national audits.

我们对 Klick 进行了评估,这是一种以护士为主导的数字化艾滋病门诊护理模式,于 2020 年推出。Klick 的智能手机应用程序提供在线预约、远程护士咨询和结果。我们根据 BHIVA 监测指南对 Klick 护士主导的咨询进行了审核,并就护士的经验进行了访谈。在接受审核的 40 名 Klick 患者中,有 4 人达到了 BHIVA 的 5 项标准:100%的患者记录了共同用药、吸烟史、血压和病毒载量数据,89%的患者接受了心血管风险计算(目标97%-90%-90%-90%-90%)。与全国 BHIVA 审计结果相比,克里克在 24 项可比指标中的 22 项指标上表现更佳。护士们安全地管理了一批具有一定复杂性的患者(如合并疾病、多重药物治疗);没有病例脱离治疗路径,而且所有病例都得到了病毒抑制。利用数字化支持模式,护士有效地为健康状况基本稳定的 HIV 阳性患者提供了安全护理,使顾问能够专注于更复杂的病例。护理工作全面且以人为本,与之前的全国性审计相比,取得了更好的成果。
{"title":"Clinical Outcomes of a Nurse-Delivered, Technology-Enabled HIV Outpatient Model.","authors":"Sara Day, Rebecca Wilkins, Andrew Murungi, Christina Antoniadi, Yodit Fissahaye-Yimer, Samuel Ohene-Adomako, David Asboe, Caroline Rae","doi":"10.1177/23259582241274304","DOIUrl":"10.1177/23259582241274304","url":null,"abstract":"<p><p>We evaluated Klick, a nurse-led, digitally enabled model of HIV outpatient care, launched in 2020. Klick's smartphone app offers online booking, remote nurse-led consultations, and results. An audit of Klick nurse-led consultations was conducted against BHIVA monitoring guidelines, and nurses were interviewed about their experience. Of 40 Klick patients audited, 4 of 5 BHIVA standards were met: 100% had documented co-medications, smoking history, blood pressure, and viral load data, and 89% received a cardiovascular risk calculation (Targets 97%-90%-90%-90%-90%). Compared to national BHIVA audit findings, Klick performed better across 22 of 24 comparable measures. Nurses safely managed a cohort comprising some complexity (eg, co-morbidities, polypharmacy); no cases were escalated off the pathway, and all were virologically suppressed. Using a digitally supported model, nurses effectively provided safe care to HIV-positive patients with predominantly stable health, enabling consultants to focus on more complex caseloads. Care was comprehensive and person-centered and obtained better outcomes compared to previous national audits.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"23 ","pages":"23259582241274304"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11440533/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142289968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of the UNAIDS Incidence Patterns Model to Determine the Distribution of New HIV Infection in Lagos State, Nigeria. 应用联合国艾滋病规划署发病模式模型确定尼日利亚拉各斯州艾滋病毒新感染者的分布情况。
IF 2.2 Q3 INFECTIOUS DISEASES Pub Date : 2024-01-01 DOI: 10.1177/23259582241238653
Toriola Femi-Adebayo, Monsurat Adeleke, Bisola Adebayo, Temitope Fadiya, Bukola Popoola, Opeyemi Ogundimu, Funmilade O Adepoju, Ayotomiwa Salawu, Oladipupo Fisher, Olusegun Ogboye, Leopold Zekeng

Background: Identifying patterns in the distribution of new HIV infections in the population is critical for HIV programmatic interventions. This study aimed to determine the distribution of New HIV infection by applying the incidence patterns mathematical model to data from Lagos state.

Methods: The incidence patterns model (IPM) software is a mathematical model developed by UNAIDS to estimate the demographic and epidemic patterns of HIV infections. This model was adapted in Lagos state to predict the distribution of new HIV infections among specified risk groups in the next 12 months.

Results: The IPM predicted a total HIV incidence of 37 cases per 100 000 individuals (3979 new infections) will occur among the 15 to 49 subpopulations. The results also showed that sero-concordant HIV-negative couples with external partners (29%), female sex workers (26%), men-having-sex-with-men (18%), and previously married females (6%) accounted for the majority of the estimated new HIV infections. Overall, key populations constitute almost half (48%) of the estimated number of new HIV infections.

Conclusion: The study helped to identify the population groups contributing significantly to new HIV infections. Therefore, priority interventions should be focused on these groups.

背景:确定艾滋病毒新感染者在人群中的分布模式对于艾滋病毒计划干预至关重要。本研究旨在通过将发病模式数学模型应用于拉各斯州的数据,确定艾滋病毒新感染者的分布情况:发病模式模型 (IPM) 软件是联合国艾滋病规划署开发的一种数学模型,用于估算艾滋病病毒感染的人口和流行模式。拉各斯州对该模型进行了调整,以预测未来 12 个月特定风险人群中新感染艾滋病毒的分布情况:根据 IPM 预测,在 15 至 49 岁的亚人群中,艾滋病毒总发病率为每 10 万人 37 例(3979 例新感染病例)。结果还显示,与外部伴侣血清一致的艾滋病毒阴性夫妇(29%)、女性性工作者(26%)、男男性行为者(18%)和已婚女性(6%)占艾滋病毒新感染者估计数的大多数。总体而言,重点人群占艾滋病毒新感染者估计人数的近一半(48%):这项研究有助于确定对新增艾滋病毒感染有重大影响的人群。因此,应优先对这些群体采取干预措施。
{"title":"Application of the UNAIDS Incidence Patterns Model to Determine the Distribution of New HIV Infection in Lagos State, Nigeria.","authors":"Toriola Femi-Adebayo, Monsurat Adeleke, Bisola Adebayo, Temitope Fadiya, Bukola Popoola, Opeyemi Ogundimu, Funmilade O Adepoju, Ayotomiwa Salawu, Oladipupo Fisher, Olusegun Ogboye, Leopold Zekeng","doi":"10.1177/23259582241238653","DOIUrl":"10.1177/23259582241238653","url":null,"abstract":"<p><strong>Background: </strong>Identifying patterns in the distribution of new HIV infections in the population is critical for HIV programmatic interventions. This study aimed to determine the distribution of New HIV infection by applying the incidence patterns mathematical model to data from Lagos state.</p><p><strong>Methods: </strong>The incidence patterns model (IPM) software is a mathematical model developed by UNAIDS to estimate the demographic and epidemic patterns of HIV infections. This model was adapted in Lagos state to predict the distribution of new HIV infections among specified risk groups in the next 12 months.</p><p><strong>Results: </strong>The IPM predicted a total HIV incidence of 37 cases per 100 000 individuals (3979 new infections) will occur among the 15 to 49 subpopulations. The results also showed that sero-concordant HIV-negative couples with external partners (29%), female sex workers (26%), men-having-sex-with-men (18%), and previously married females (6%) accounted for the majority of the estimated new HIV infections. Overall, key populations constitute almost half (48%) of the estimated number of new HIV infections.</p><p><strong>Conclusion: </strong>The study helped to identify the population groups contributing significantly to new HIV infections. Therefore, priority interventions should be focused on these groups.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"23 ","pages":"23259582241238653"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10956134/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140175173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of Frailty Phenotypes in Older People Living with HIV: A Cross-Sectional Study from Brazil. 巴西一项横断面研究:感染艾滋病毒的老年人中虚弱表型的流行率:巴西的一项横断面研究
IF 2.2 Q3 INFECTIOUS DISEASES Pub Date : 2024-01-01 DOI: 10.1177/23259582241241169
Susana Lilian Wiechmann, Alexandre Mestre Tejo, Manuel Victor Silva Inácio, Arthur Eumann Mesas, Marcos Aparecido Sarria Cabrera

Background: Frailty may affect people living with HIV (PLHIV) prematurely. Fried's frailty phenotype, composed of 5 criteria, is one of the most used instruments for its assessment. This study aimed to determine the prevalence of these criteria among PLHIV classified as prefrail and frail in Brazil.

Methods: A cross-sectional study analyzed the prevalence of the Frailty Phenotype in Brazil with 670 individuals aged ≥ 50 years and undetectable viral load.

Results: The prevalence of prefrail and frail individuals was 50.7% and 13.6%, respectively. A low level of physical activity was the most prevalent criterion (50.9%). Except for unintentional weight loss, all other criteria were more prevalent among individuals with lower education levels. All criteria were more prevalent among individuals of lower socioeconomic status than among those of moderate or high status (P < .05).

Conclusions: A low level of physical activity was the component that most contributed to PLHIV being considered prefrail or frail.

背景:虚弱可能会过早影响艾滋病病毒感染者(PLHIV)。弗里德虚弱表型由 5 项标准组成,是最常用的评估工具之一。本研究旨在确定这些标准在巴西被归类为前体弱和体弱的艾滋病毒感染者中的流行率:一项横断面研究分析了巴西 670 名年龄≥ 50 岁且病毒载量检测不到的个体中体弱表型的流行情况:结果:体弱前型和体弱后型的患病率分别为 50.7% 和 13.6%。体力活动少是最普遍的标准(50.9%)。除无意中体重减轻外,所有其他标准在受教育程度较低的人群中都更为普遍。所有标准在社会经济地位较低的人群中都比在社会经济地位中等或较高的人群中更普遍(P 结 论):体力活动水平低是导致艾滋病毒感染者被认为是体弱多病的最主要因素。
{"title":"Prevalence of Frailty Phenotypes in Older People Living with HIV: A Cross-Sectional Study from Brazil.","authors":"Susana Lilian Wiechmann, Alexandre Mestre Tejo, Manuel Victor Silva Inácio, Arthur Eumann Mesas, Marcos Aparecido Sarria Cabrera","doi":"10.1177/23259582241241169","DOIUrl":"10.1177/23259582241241169","url":null,"abstract":"<p><strong>Background: </strong>Frailty may affect people living with HIV (PLHIV) prematurely. Fried's frailty phenotype, composed of 5 criteria, is one of the most used instruments for its assessment. This study aimed to determine the prevalence of these criteria among PLHIV classified as prefrail and frail in Brazil.</p><p><strong>Methods: </strong>A cross-sectional study analyzed the prevalence of the Frailty Phenotype in Brazil with 670 individuals aged ≥ 50 years and undetectable viral load.</p><p><strong>Results: </strong>The prevalence of prefrail and frail individuals was 50.7% and 13.6%, respectively. A low level of physical activity was the most prevalent criterion (50.9%). Except for unintentional weight loss, all other criteria were more prevalent among individuals with lower education levels. All criteria were more prevalent among individuals of lower socioeconomic status than among those of moderate or high status (<i>P</i> < .05).</p><p><strong>Conclusions: </strong>A low level of physical activity was the component that most contributed to PLHIV being considered prefrail or frail.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"23 ","pages":"23259582241241169"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11078087/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140876726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transfusion-Transmissible Infections Among Blood Donors in a Regional Hospital in Ghana: A 6-Year Trend Analysis (2017-2022). 加纳一家地区医院献血者中的输血传播性传染病:6年趋势分析(2017-2022年)》。
IF 2.2 Q3 INFECTIOUS DISEASES Pub Date : 2024-01-01 DOI: 10.1177/23259582241274305
Priscilla Yeboah Hadfield, Godwin Adjei Vechey, Emmanuel Bansah, Morkporkpor Nyahe, Nelisiwe Khuzwayo, Elvis Enowbeyang Tarkang

Background: This study determined the trends of transfusion-transmissible infections (TTIs) among blood donors in a regional hospital in Ghana from 2017 to 2022.

Methods: A retrospective analysis was conducted on 6339 blood donor records. Data were analyzed using STATA version 17.0 at the 0.05 significance level.

Results: The prevalence of TTIs was 31.4% in 2017, 13.8% in 2018, 20.4% in 2019, 9.5% in 2020, 9.6% in 2021, and 11.7% in 2022. There were significant associations between hepatitis C virus (HCV), Syphilis, and sex (OR = 2.06; 95% CI [1.29-3.30]; P = .003) and (OR = 2.28; 95% CI [1.48-3.54]; P < .001), respectively. Blood donors aged 20-29 were more likely to be infected with hepatitis B virus (OR = 1.96; 95% CI [1.28-2.99]; P = .002). Blood donors aged 40-49 had higher odds of infection with HCV (OR = 3.36; 95% CI [2.02-5.57]; P < .001) and Syphilis (OR = 3.79; 95% CI [2.45-5.87]; P < .001).

Conclusion: The study highlights the need to implement targeted prevention strategies for donors with a higher TTI prevalence.

背景:本研究确定了2017年至2022年加纳一家地区医院献血者中输血传播感染(TTIs)的趋势:对 6339 份献血者记录进行了回顾性分析。数据采用 STATA 17.0 版进行分析,显著性水平为 0.05:2017年TTI的患病率为31.4%,2018年为13.8%,2019年为20.4%,2020年为9.5%,2021年为9.6%,2022年为11.7%。丙型肝炎病毒(HCV)、梅毒与性别(OR = 2.06;95% CI [1.29-3.30];P = .003)和(OR = 2.28;95% CI [1.48-3.54];P P = .002)之间存在明显关联。40-49 岁献血者感染 HCV 的几率更高(OR = 3.36;95% CI [2.02-5.57];P P 结论:本研究强调了对 TTI 感染率较高的献血者实施有针对性的预防策略的必要性。
{"title":"Transfusion-Transmissible Infections Among Blood Donors in a Regional Hospital in Ghana: A 6-Year Trend Analysis (2017-2022).","authors":"Priscilla Yeboah Hadfield, Godwin Adjei Vechey, Emmanuel Bansah, Morkporkpor Nyahe, Nelisiwe Khuzwayo, Elvis Enowbeyang Tarkang","doi":"10.1177/23259582241274305","DOIUrl":"10.1177/23259582241274305","url":null,"abstract":"<p><strong>Background: </strong>This study determined the trends of transfusion-transmissible infections (TTIs) among blood donors in a regional hospital in Ghana from 2017 to 2022.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 6339 blood donor records. Data were analyzed using STATA version 17.0 at the 0.05 significance level.</p><p><strong>Results: </strong>The prevalence of TTIs was 31.4% in 2017, 13.8% in 2018, 20.4% in 2019, 9.5% in 2020, 9.6% in 2021, and 11.7% in 2022. There were significant associations between hepatitis C virus (HCV), Syphilis, and sex (OR = 2.06; 95% CI [1.29-3.30]; <i>P</i> = .003) and (OR = 2.28; 95% CI [1.48-3.54]; <i>P</i> < .001), respectively. Blood donors aged 20-29 were more likely to be infected with hepatitis B virus (OR = 1.96; 95% CI [1.28-2.99]; <i>P</i> = .002). Blood donors aged 40-49 had higher odds of infection with HCV (OR = 3.36; 95% CI [2.02-5.57]; <i>P</i> < .001) and Syphilis (OR = 3.79; 95% CI [2.45-5.87]; <i>P</i> < .001).</p><p><strong>Conclusion: </strong>The study highlights the need to implement targeted prevention strategies for donors with a higher TTI prevalence.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"23 ","pages":"23259582241274305"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11342317/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142036174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Implications of HIV Treatment and Prevention for Polygamous Families in Kenya and Uganda: "My Co-Wife Is the One Who Used to Encourage Me". 肯尼亚和乌干达一夫多妻制家庭艾滋病治疗和预防的临床意义:"我的同妻曾经鼓励过我"。
IF 2.2 Q3 INFECTIOUS DISEASES Pub Date : 2024-01-01 DOI: 10.1177/23259582241255171
Jason Johnson-Peretz, Anjeline Onyango, Sarah A Gutin, Laura Balzer, Cecilia Akatukwasa, Lawrence Owino, Titus M O Arunga, Fred Atwine, Maya Petersen, Moses Kamya, James Ayieko, Ted Ruel, Diane Havlir, Carol S Camlin

Polygamy is the practice of marriage to multiple partners. Approximately 6-11% of households in Uganda and 4-11% of households in Kenya are polygamous. The complex families produced by polygamous marriage customs give rise to additional considerations for healthcare providers and public health messaging around HIV care. Using 27 in-depth, semi-structured qualitative interviews with participants in two studies in rural Kenya and Uganda, we analysed challenges and opportunities that polygamous families presented in the diagnosis, treatment and prevention of HIV, and provider roles in improving HIV outcomes in these families. Overall, prevention methods seemed more justifiable to families where co-wives live far apart than when all members live in the same household. In treatment, diagnosis of one member did not always lead to disclosure to other members, creating an adverse home environment; but sometimes diagnosis of one wife led not only to diagnosis of the other, but also to greater household support.

一夫多妻制是与多个伴侣结婚的习俗。乌干达约有 6-11% 的家庭和肯尼亚约有 4-11% 的家庭实行一夫多妻制。一夫多妻制婚姻习俗所产生的复杂家庭给医疗服务提供者和围绕艾滋病护理的公共卫生信息提供者带来了更多的考虑。通过对肯尼亚和乌干达农村地区两项研究的参与者进行 27 次深入的半结构化定性访谈,我们分析了一夫多妻制家庭在诊断、治疗和预防艾滋病方面所面临的挑战和机遇,以及医疗服务提供者在改善这些家庭艾滋病治疗效果方面所扮演的角色。总体而言,与所有成员都生活在同一个家庭相比,预防方法似乎更适用于共同妻子分居两地的家庭。在治疗方面,对一名成员的诊断并不总是导致向其他成员披露,从而造成不利的家庭环境;但有时对一名妻子的诊断不仅导致对另一名妻子的诊断,而且还带来了更多的家庭支持。
{"title":"Clinical Implications of HIV Treatment and Prevention for Polygamous Families in Kenya and Uganda: \"My Co-Wife Is the One Who Used to Encourage Me\".","authors":"Jason Johnson-Peretz, Anjeline Onyango, Sarah A Gutin, Laura Balzer, Cecilia Akatukwasa, Lawrence Owino, Titus M O Arunga, Fred Atwine, Maya Petersen, Moses Kamya, James Ayieko, Ted Ruel, Diane Havlir, Carol S Camlin","doi":"10.1177/23259582241255171","DOIUrl":"10.1177/23259582241255171","url":null,"abstract":"<p><p>Polygamy is the practice of marriage to multiple partners. Approximately 6-11% of households in Uganda and 4-11% of households in Kenya are polygamous. The complex families produced by polygamous marriage customs give rise to additional considerations for healthcare providers and public health messaging around HIV care. Using 27 in-depth, semi-structured qualitative interviews with participants in two studies in rural Kenya and Uganda, we analysed challenges and opportunities that polygamous families presented in the diagnosis, treatment and prevention of HIV, and provider roles in improving HIV outcomes in these families. Overall, prevention methods seemed more justifiable to families where co-wives live far apart than when all members live in the same household. In treatment, diagnosis of one member did not always lead to disclosure to other members, creating an adverse home environment; but sometimes diagnosis of one wife led not only to diagnosis of the other, but also to greater household support.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"23 ","pages":"23259582241255171"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11100383/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140945415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Service Interruption in HIV Care Amid COVID-19 Pandemic in Myanmar: Results From Analysis of Routine Program Data 2018-2022. 缅甸COVID-19大流行期间艾滋病毒护理服务中断:2018-2022年常规项目数据分析结果
IF 2.2 Q3 INFECTIOUS DISEASES Pub Date : 2024-01-01 DOI: 10.1177/23259582241299466
Myat Khaing, Sein Lwin, Naw Paw, Zun Htet, Lynn Htet, Hein Ko, May Thet
<p><strong>Background: </strong>COVID-19 pandemic disrupted organized HIV screening efforts, HIV testing and management worldwide, and the impact of these disruptions from private HIV care clinics have not been examined in Myanmar. PSI/Myanmar had adapted through partner clinics, Sun Quality Health Clinics (SQH) and Lan Pya Kyel clinics (LPK), with measures like online booking, staff scheduling and awareness campaigns. The purpose of this paper was to describe whether HIV-related services changed before, during, and after the COVID-19 pandemic in Myanmar. This study aimed to identify factors influencing ART retention and VL testing.</p><p><strong>Methodology: </strong>Data from 43 healthcare facilities across 8 regions (2018-2022) was analyzed for HIV indicators, including HIV tests, positive cases, ART retention, viral load (VL) testing, and suppression rates in two channels during different phases.</p><p><strong>Results: </strong>During the COVID-19 pandemic, both Channel 1 (SQH) and Channel 2 (LPK) showed fluctuations in HIV testing and new positive cases. Channel 1 had 28.2% decrease in testing (37 735 fewer tests) while Channel 2 had 8.1% increase (81 596 tests). However, testing numbers continued to decline. ART retention declined over 12 months compared to 6 months for both channels. Channel 1 had a slight drop in 6-month retention during the crisis (89.3-88.1%) but an increase in 12-month retention after. Channel 2 maintained high 6-month retention rates (>90%) but varied in 12-month rates (from 80.1% to 92.9%). Unsuccessful outcomes were more common at 12 months in both channels (4.7-21.8% in Channel 1; 7.1-19.9% in Channel 2). VL testing at 12 months significantly decreased during the crisis, notably in Channel 2 (81.9-1.3%). However, high rates of VL suppression (>91%) were consistently seen in those tested in both channels before, during, and after COVID-19. Univariable and multivariable cox proportional hazards models were used to identify factors influencing ART retention. Univariable and multivariable logistic regression analyses were done for VL testing. Factors such as residence location, the period of COVID-19, use of second-line ART, and patient demographics (such as age and key population type) influenced both. Specifically, individuals seeking care from Mandalay [aHR = 1.37, <i>P</i> value < 0.01], and enrolled for ART during or after COVID-19 [aHR = 3.31, <i>P</i> value < 0.01], were more likely to be retained at 12 months. VL testing was positively associated with having no TB [aOR = 1.35, <i>P</i> value < 0.01], being MSM [aOR = 1.69, <i>P</i> value < 0.01], PWIDs [aOR = 2.51, <i>P</i> value < 0.01], and seeking care at Channel 2[aOR = 1.76, <i>P</i> value < 0.01].</p><p><strong>Conclusion: </strong>The study highlighted interruption in ART retention and VL testing because of the COVID-19 pandemic, emphasizing the need to maintain essential HIV services and address gaps based on patient demographics, clinic type, ART enrol
背景:COVID-19大流行扰乱了全世界有组织的艾滋病毒筛查工作、艾滋病毒检测和管理,缅甸尚未对私营艾滋病毒护理诊所造成的这些破坏的影响进行研究。PSI/缅甸通过合作诊所,太阳质量健康诊所(SQH)和Lan Pya Kyel诊所(LPK)进行了调整,采取了在线预订、工作人员安排和宣传活动等措施。本文的目的是描述缅甸在COVID-19大流行之前,期间和之后艾滋病毒相关服务是否发生了变化。本研究旨在确定影响ART保留和VL检测的因素。方法:分析了来自8个地区43家医疗机构(2018-2022年)的艾滋病毒指标,包括艾滋病毒检测、阳性病例、抗逆转录病毒药物保留率、病毒载量(VL)检测和两个渠道在不同阶段的抑制率。结果:在2019冠状病毒病大流行期间,1通道(SQH)和2通道(LPK)的HIV检测和新发阳性病例均出现波动。通道1的检测次数减少了28.2%(减少了37 735次),而通道2的检测次数增加了8.1%(81 596次)。然而,测试数量继续下降。与两个渠道的6个月相比,ART保留率在12个月内有所下降。第一频道在危机期间6个月的留存率略有下降(89.3-88.1%),但在危机后12个月的留存率有所上升。渠道2维持了较高的6个月留存率(约90%),但12个月的留存率有所变化(从80.1%到92.9%)。两种通道在12个月时不成功的情况更为常见(通道1为4.7% -21.8%;在危机期间,12个月的VL测试显著下降,特别是在通道2(81.9-1.3%)。然而,在COVID-19之前、期间和之后,在两个通道中测试的患者中,VL抑制率一直很高(bbb91 %)。采用单变量和多变量cox比例风险模型确定影响ART保留的因素。对VL检验进行单变量和多变量logistic回归分析。居住地、COVID-19病程、二线抗逆转录病毒治疗的使用以及患者人口统计学(如年龄和重点人群类型)等因素对两者都有影响。结论:该研究强调了由于COVID-19大流行而中断抗逆转录病毒治疗和VL检测的情况,强调需要维持基本的艾滋病毒服务,并根据患者人口统计学、诊所类型、抗逆转录病毒治疗登记期和地点解决差距。某些因素在影响这些结果方面发挥了作用,为在类似危机情况下改善艾滋病毒护理和治疗的潜在领域提供了见解,以确保持续和有效的艾滋病毒护理。
{"title":"Service Interruption in HIV Care Amid COVID-19 Pandemic in Myanmar: Results From Analysis of Routine Program Data 2018-2022.","authors":"Myat Khaing, Sein Lwin, Naw Paw, Zun Htet, Lynn Htet, Hein Ko, May Thet","doi":"10.1177/23259582241299466","DOIUrl":"10.1177/23259582241299466","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;COVID-19 pandemic disrupted organized HIV screening efforts, HIV testing and management worldwide, and the impact of these disruptions from private HIV care clinics have not been examined in Myanmar. PSI/Myanmar had adapted through partner clinics, Sun Quality Health Clinics (SQH) and Lan Pya Kyel clinics (LPK), with measures like online booking, staff scheduling and awareness campaigns. The purpose of this paper was to describe whether HIV-related services changed before, during, and after the COVID-19 pandemic in Myanmar. This study aimed to identify factors influencing ART retention and VL testing.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methodology: &lt;/strong&gt;Data from 43 healthcare facilities across 8 regions (2018-2022) was analyzed for HIV indicators, including HIV tests, positive cases, ART retention, viral load (VL) testing, and suppression rates in two channels during different phases.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;During the COVID-19 pandemic, both Channel 1 (SQH) and Channel 2 (LPK) showed fluctuations in HIV testing and new positive cases. Channel 1 had 28.2% decrease in testing (37 735 fewer tests) while Channel 2 had 8.1% increase (81 596 tests). However, testing numbers continued to decline. ART retention declined over 12 months compared to 6 months for both channels. Channel 1 had a slight drop in 6-month retention during the crisis (89.3-88.1%) but an increase in 12-month retention after. Channel 2 maintained high 6-month retention rates (&gt;90%) but varied in 12-month rates (from 80.1% to 92.9%). Unsuccessful outcomes were more common at 12 months in both channels (4.7-21.8% in Channel 1; 7.1-19.9% in Channel 2). VL testing at 12 months significantly decreased during the crisis, notably in Channel 2 (81.9-1.3%). However, high rates of VL suppression (&gt;91%) were consistently seen in those tested in both channels before, during, and after COVID-19. Univariable and multivariable cox proportional hazards models were used to identify factors influencing ART retention. Univariable and multivariable logistic regression analyses were done for VL testing. Factors such as residence location, the period of COVID-19, use of second-line ART, and patient demographics (such as age and key population type) influenced both. Specifically, individuals seeking care from Mandalay [aHR = 1.37, &lt;i&gt;P&lt;/i&gt; value &lt; 0.01], and enrolled for ART during or after COVID-19 [aHR = 3.31, &lt;i&gt;P&lt;/i&gt; value &lt; 0.01], were more likely to be retained at 12 months. VL testing was positively associated with having no TB [aOR = 1.35, &lt;i&gt;P&lt;/i&gt; value &lt; 0.01], being MSM [aOR = 1.69, &lt;i&gt;P&lt;/i&gt; value &lt; 0.01], PWIDs [aOR = 2.51, &lt;i&gt;P&lt;/i&gt; value &lt; 0.01], and seeking care at Channel 2[aOR = 1.76, &lt;i&gt;P&lt;/i&gt; value &lt; 0.01].&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;The study highlighted interruption in ART retention and VL testing because of the COVID-19 pandemic, emphasizing the need to maintain essential HIV services and address gaps based on patient demographics, clinic type, ART enrol","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"23 ","pages":"23259582241299466"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11626658/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142794938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient Participant Perspectives on Implementation of Long-Acting Cabotegravir and Rilpivirine: Results From the Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL) Study. 患者参与者对长效卡博特拉韦和利匹韦林实施情况的看法:欧洲卡博替拉韦和利匹韦林实施研究(CARISEL)的结果。
IF 2.2 Q3 INFECTIOUS DISEASES Pub Date : 2024-01-01 DOI: 10.1177/23259582241269837
Cassidy A Gutner, Marc van der Valk, Joaquin Portilla, Eliette Jeanmaire, Leïla Belkhir, Thomas Lutz, Rebecca DeMoor, Rekha Trehan, Jenny Scherzer, Miguel Pascual-Bernáldez, Mounir Ait-Khaled, Beatriz Hernandez, Annemiek de Ruiter, Savita Bakhshi Anand, Emma L Low, Monica Hadi, Nicola Barnes, Nick Sevdalis, Perry Mohammed, Maggie Czarnogorski

Introduction: CARISEL is an implementation-effectiveness "hybrid" study examining the perspectives of people living with HIV-1 (patient study participants [PSPs]) on cabotegravir (CAB) plus rilpivirine (RPV) long-acting (LA) dosed every 2 months (Q2M) across 5 European countries.

Methods: PSPs completed questionnaires on acceptability (Acceptability of Intervention Measure), appropriateness (Intervention Appropriateness Measure), and feasibility (Feasibility of Intervention Measure) at their first (Month [M] 1), third (M4), and seventh (M12) injection visits. Semistructured qualitative interviews were also conducted.

Results: Overall, 437 PSPs were enrolled, of whom 430 received treatment. Median (interquartile range) age was 44 (37-51) years, 25.3% (n = 109/430) were female (sex at birth), and 21.9% (n = 94/430) were persons of color. Across time points, PSPs found CAB + RPV LA highly acceptable, appropriate, and feasible (mean scores ≥4.47/5). Qualitative data supported these observations.

Conclusions: PSPs found CAB + RPV LA Q2M to be an acceptable, appropriate, and feasible treatment option.

简介:CARISEL 是一项实施效果 "混合 "研究:CARISEL是一项实施效果 "混合 "研究,考察了欧洲5个国家的HIV-1感染者(患者研究参与者[PSPs])对卡博替拉韦(CAB)加利匹韦林(RPV)长效(LA)每2个月(Q2M)用药的看法:PSPs 在第一次(Month [M] 1)、第三次(M4)和第七次(M12)注射时填写了关于可接受性(干预可接受性测量)、适当性(干预适当性测量)和可行性(干预可行性测量)的问卷。此外,还进行了半结构化定性访谈:总共有 437 名 PSP 参与,其中 430 人接受了治疗。年龄中位数(四分位数间距)为 44(37-51)岁,25.3%(n = 109/430)为女性(出生时性别),21.9%(n = 94/430)为有色人种。在各个时间点,PSP 都认为 CAB + RPV LA 非常可接受、合适和可行(平均得分≥4.47/5)。定性数据支持这些观察结果:PSPs 认为 CAB + RPV LA Q2M 是一种可接受的、适当的和可行的治疗方案。
{"title":"Patient Participant Perspectives on Implementation of Long-Acting Cabotegravir and Rilpivirine: Results From the Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL) Study.","authors":"Cassidy A Gutner, Marc van der Valk, Joaquin Portilla, Eliette Jeanmaire, Leïla Belkhir, Thomas Lutz, Rebecca DeMoor, Rekha Trehan, Jenny Scherzer, Miguel Pascual-Bernáldez, Mounir Ait-Khaled, Beatriz Hernandez, Annemiek de Ruiter, Savita Bakhshi Anand, Emma L Low, Monica Hadi, Nicola Barnes, Nick Sevdalis, Perry Mohammed, Maggie Czarnogorski","doi":"10.1177/23259582241269837","DOIUrl":"10.1177/23259582241269837","url":null,"abstract":"<p><strong>Introduction: </strong>CARISEL is an implementation-effectiveness \"hybrid\" study examining the perspectives of people living with HIV-1 (patient study participants [PSPs]) on cabotegravir (CAB) plus rilpivirine (RPV) long-acting (LA) dosed every 2 months (Q2M) across 5 European countries.</p><p><strong>Methods: </strong>PSPs completed questionnaires on acceptability (Acceptability of Intervention Measure), appropriateness (Intervention Appropriateness Measure), and feasibility (Feasibility of Intervention Measure) at their first (Month [M] 1), third (M4), and seventh (M12) injection visits. Semistructured qualitative interviews were also conducted.</p><p><strong>Results: </strong>Overall, 437 PSPs were enrolled, of whom 430 received treatment. Median (interquartile range) age was 44 (37-51) years, 25.3% (n = 109/430) were female (sex at birth), and 21.9% (n = 94/430) were persons of color. Across time points, PSPs found CAB + RPV LA highly acceptable, appropriate, and feasible (mean scores ≥4.47/5). Qualitative data supported these observations.</p><p><strong>Conclusions: </strong>PSPs found CAB + RPV LA Q2M to be an acceptable, appropriate, and feasible treatment option.</p>","PeriodicalId":17328,"journal":{"name":"Journal of the International Association of Providers of AIDS Care","volume":"23 ","pages":"23259582241269837"},"PeriodicalIF":2.2,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11367594/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142108694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the International Association of Providers of AIDS Care
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1